34. Hermanson M, Nistér M, Betsholtz C, Heldin CH, Westermark B, Funa K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA. 1988; 85:7748–52. 35. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 1992;52: 3213–19. 36. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Can- cer Res. 1996;56:164–71. 37. De Bustos C, Smits A, Strömberg B, Collins VP, Nistér M, Aﬁnk G. A PDGFRA promoter polymorphism, which dis- rupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas. J Med Genet. 2005;42:31–7. 38. Toepoel M, Joosten PH, Knobbe CB, Aﬁnk GB, Zotz RB, Steegers-Theunissen RP, et al. Haplotype-speciﬁc expression of the human PDGFRA gene correlates with the risk of glioblastomas. Int J Cancer. 2008;123:322–9. 39. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldﬁeld EH, Aaranson SA, et al. Ampliﬁcation and/or over- expression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res. 1992;52:4550–3. 40. Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glio- blastoma cells: evidence that the novel PDGF-C and PDGF- D ligands may play a role in the development of brain tumors. Cancer Res. 2002;62:3729–35. 41. Beckmann MP, Betsholtz C, Heldin C-H, Westermark B, Di Marco E, Di Fiore PP, et al. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science. 1988;241:1346–9. 42. Vassbotn FS, Ostman A, Langeland N, Holmsen H, Westermark B, Heldin CH, et al. Activated platelet-derived growth factor autocrine pathway drives the transformed phe- notype of a human glioblastoma cell line. J Cell Physiol. 1994; 158:381–9. 43. Strawn LM, Mann E, Elliger SS, Chu LM, Germain LL, Niederfellner G, et al. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. J Biol Chem. 1994;269:21215–22. 44. Dresemann G, Weller M, Rosenthal MA, Wedding U, Wagner W, Engel E, et al. Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. J Neurooncol. 2010;96:393–402. 45. Reardon DA, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, et al. Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. Br J Cancer. 2009;101: 1995–2004. 46. Hägerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, Ostman A, et al. Identiﬁcation of a SOX2- dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity proﬁle. Neuro Oncol. 2011;13:11178–91. PDGF and PDGF receptors in glioma 109 47. Holmberg J, He X, Peredo I, Orrego A, Hesselager G, Ericsson C, et al. Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma. PLoS ONE. 2011;6:e18454. 48. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult ﬁbroblast cultures by deﬁned factors. Cell. 2006;126:663–76. 49. Betsholtz C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev. 2004;15:215–28. 50. Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, et al. PDGF-A signaling is a critical event in lung alveolar myoﬁbroblast development and alveogenesis. Cell. 1996;85:863–73. 51. Ding H, Wu X, Boström H, Kim I, Wong N, Tsoi B, et al. A speciﬁc requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat Genet. 2004;36:1111–16. 52. Levéen P, Pekny M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C. Mice deﬁcient for PDGF B show renal, cardio- vascular, and hematological abnormalities. Genes Dev. 1994; 8:1875–87. 53. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994;8:1888–96. 54. Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development. 1997;124:2691–700. 55. Lindahl P, Johansson BR, Levéen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deﬁcient mice. Science. 1997;277:242–5. 56. Lindahl P, Karlsson L, Hellström M, Gebre-Medhin S, Willetts K, Heath JK, et al. Alveogenesis failure in PDGF- A-deﬁcient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development. 1997;124:3943–53. 57. Klinghoffer RA, Mueting-Nelson PF, Faerman A, Shani M, Soriano P. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell. 2001;7:343–54. 58. Klinghoffer RA, Hamilton TG, Hoch R, Soriano P. An allelic series at the PDGFalphaR locus indicates unequal contribu- tions of distinct signaling pathways during development. Dev Cell. 2002;2:103–13. 59. Göritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisén J. A pericyte origin of spinal cord scar tissue. Science. 2011;333:238–42. 60. Sasahara M, Fries JW, Raines EW, Gown AM, Westrum LE, Frosch MP, et al. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell. 1991;64:217–27. 61. Egawa-Tsuzuki T, Ohno M, Tanaka N, Takeuchi Y, Uramoto H, Faigle R, et al. The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol. 2004;186:89–98. 62. Ishii Y, Oya T, Zheng L, Gao Z, Kawaguchi M, Sabit H, et al. Mouse brains deﬁcient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury. J Neurochem. 2006;98:588–600. 63. Smits A, Kato M, Westermark B, Nister M, Heldin CH, Funa K. Neurotrophic activity of platelet-derived growth factor (PDGF): Rat neuronal cells possess functional PDGF beta-type receptors and respond to PDGF. Proc Natl Acad Sci USA. 1991;88:8159–63. 64. Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in